Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
163 search results
Could mRNA vaccine be the flu interventions of tomorrow?
We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.
How a drug approval changed the lives of patients living with rare disease.
Is autologous cell therapy a realistic proposition for solid tumors?
Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne.
Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.
Can AI facilitate a grand comeback for medicines sourced from Mother Nature?
We interview Mary Lavin, President of Sartorius North America, about her career.
Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.
We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Painted Cells and Scrambled Jigsaws
The Time is Now for Digitally Simplified Bioprocessing
ADCs: Still Room for Improvement!